The honest answer to “What are the side effects of NAD+ supplements?” is that the human evidence for swallowing NAD+ itself is still thin. NAD+ is essential inside cells. That fact tells us almost nothing about how a particular capsule will feel, whether it interacts with your medication, or what daily use over years might do. Biology is a starting point for a safety question, not the answer.
Search results often mix oral NAD+ capsules with nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), injections, and IV infusions. Those are different ingredients or delivery routes. This guide stays focused on oral NAD+ and treats evidence from its relatives as context, not a substitute. NAD+ is the coenzyme your cells use in energy metabolism; its cellular role does not settle supplement safety.
The short answer
Published human research directly testing oral NAD+ is much smaller than the research on NAD+ precursors. A 2026 randomized study tested a proprietary oral powder for five days and measured blood biomarkers. It was not designed to establish long-term safety, and its formulation and dose differ from a typical capsule. There is no reliable incidence table that lets us say “X% of NAD+ capsule users get headache or nausea.” If a page offers one without identifying the exact formulation and study, be skeptical.
That does not mean a capsule must be dangerous. It means the confidence level should match the data. People who are pregnant or breastfeeding, have a medical condition, take prescription drugs, or are preparing for surgery should discuss use with their clinician. If you develop a new symptom after starting any supplement, stop it and seek appropriate medical advice; urgent symptoms need urgent care.
What has actually been tested with oral NAD+?
The most relevant direct study so far gave healthy adults aged 45–75 a proprietary, modified LNAD+ powder or placebo. Sixty people were randomized; 50 were included in the primary analysis. The published Methods specify four 500 mg powder doses each day for five days, plus an extra 500 mg powder dose at night on days 2 and 3. The paper reports that NAD+ made up 50% of the powder. Participants used a swish-and-swallow protocol. The assay measured total NAD (NAD+ plus NADH), which rose in whole blood relative to placebo, while plasma total NAD did not. That is a formulation-specific blood biomarker result, predominantly reflecting red blood cells, not evidence that every oral NAD+ product behaves the same way or that NAD+ rose in all tissues.
The study reported one treatment-emergent adverse event: mild grade-1 nausea in one LNAD+ participant on day 2, resolving within 24 hours after discontinuation. Overall symptom-day incidence was comparable between treatment and placebo (2.92% versus 2.40%; p = 0.68). This describes five days with that powder in selected volunteers; it is not a nausea rate for ordinary NAD+ capsules.
Five days is a blink in supplement safety. It may reveal an immediate tolerability problem if one occurs often enough in a small sample. It cannot reliably detect uncommon reactions, delayed effects, interactions in people excluded from the trial, or what happens over months and years. The published trial also does not test the Infinite Labs capsule. A 500 mg conventional capsule with black pepper extract is materially different from a divided-dose, swish-and-swallow proprietary powder.
It is tempting to supplement that gap with trials of NMN or NR. Those compounds can feed NAD+ metabolism, but their digestion, metabolism, ingredient combinations, and doses are different. A short NMN safety meta-analysis cannot certify an NAD+ capsule. Neither can an IV clinic's experience, which involves a different route and setting.
Which symptoms should you watch for?
Any new symptom matters more than a generic internet list. Digestive upset, headache, dizziness, flushing, sleep disturbance, and palpitations are common things people search for around “NAD+,” but the available oral NAD+ capsule trials do not give dependable rates for each. Some lists accidentally borrow side effects from high-dose niacin, NR, or IV infusions. They may describe a real experience somewhere; they do not quantify the risk of the capsule in your hand.
Keep a simple record if you start a supplement: product name, lot, amount, time taken, other new products or medicines, and when a symptom began. That makes a conversation with your clinician more useful. Do not assume every symptom was caused by NAD+—or dismiss a serious one because a marketing page called the ingredient “natural.”
Stop and get urgent care for symptoms such as trouble breathing, swelling of the face or throat, severe chest pain, or fainting. For a persistent but less urgent symptom, pause the supplement and talk with a healthcare professional. You can also report a suspected supplement problem to the FDA. A report is a safety signal, not proof of causation, but it helps regulators notice patterns.
Why route matters: capsules versus IVs and injections
| Route | What enters the body | Why safety evidence differs |
|---|---|---|
| Oral capsule | Ingredient passes through digestion before systemic exposure | Evidence must reflect capsule formulation, dose, excipients, and oral use |
| Proprietary oral powder | Still oral, but particle design and composition may differ | A positive five-day trial cannot validate a different finished product |
| IV or injection | Delivered outside the digestive route by a clinician or service | Procedure, sterility, infusion rate, and route create distinct risks |
An IV anecdote about a “flush” or nausea is not evidence that swallowing NAD+ causes the same thing. Conversely, a capsule study cannot establish IV safety. If you are considering an infusion, ask that provider about their own product, route, screening, and adverse-event process. A blog about oral supplements cannot answer those procedural questions.
Who should take extra care?
Clinical trials often enroll relatively healthy volunteers and exclude people whose conditions or medications might complicate interpretation. That protects the study, but it also narrows what the results can tell you. Pregnancy and breastfeeding are major data gaps. So are many chronic illnesses, complex medication regimens, and long-term use. “Not studied” should be read literally; it is not shorthand for safe or unsafe.
Ask a clinician before use if you take prescription medication, receive treatment for a medical condition, have liver or kidney disease, or are considering NAD+ while pregnant or breastfeeding. This is particularly sensible when a formula contains additional ingredients. Our product includes 2.5 mg BioPerine® black pepper extract alongside NAD+. The label tells you what is present; it does not establish that the combination has been tested with every drug. Bring the actual Supplement Facts panel to the conversation.
Do not use a supplement to postpone diagnosis of persistent fatigue, dizziness, or unexplained symptoms. Those complaints have many possible causes. A cellular-energy story can be appealing, but it is not a diagnostic test.
How to reduce avoidable uncertainty
- Read the complete label. Check NAD+ amount per serving, number of capsules, other active ingredients, and directions. “500 mg” on the front should match the Supplement Facts context.
- Use the labeled amount. Doubling capsules because a trial used a larger dose changes exposure without showing greater benefit or safety.
- Do not stack similar products automatically. NAD+, NMN, NR, and niacin all relate to the same metabolic network; more inputs do not guarantee a better result.
- Start one new product at a time. If several things change together, it becomes harder to know what caused a symptom.
- Retain the lot number. It helps if you need to report a quality or adverse-event concern.
The FDA explains that dietary supplements are not preapproved for safety and effectiveness before marketing in the way drugs are. A retail listing, a clean-looking bottle, or an ingredient's role in metabolism does not replace finished-product testing.
Our NAD+ label, without borrowed promises
The current Infinite Labs NAD+ label lists 500 mg NAD+ and 2.5 mg BioPerine® per capsule, 30 servings per bottle, with directions to take one capsule daily with food. The other listed ingredients are a hypromellose capsule and Nu-FLOW® rice-hull flow aid. These are label facts verified against the product media on September 29, 2026. They are not clinical findings.
Most importantly, the five-day LNAD+ trial used a different formulation, route of oral administration, and dose schedule from our capsule. Its blood-cell biomarker result and short-term safety observations cannot be transferred to this capsule. If future trials test ordinary oral NAD+ capsules over longer periods, this safety answer can become more precise. For now, the defensible approach is to follow the label, keep expectations modest, and raise personal risk questions with someone who knows your medical history.
Frequently asked questions
Does oral NAD+ cause flushing?
There is no dependable rate for flushing from oral NAD+ capsules. Flushing is well known with some forms and doses of niacin, which is a different compound. Do not automatically import niacin's side-effect profile to NAD+.
Is NAD+ safe to take every day?
A few days of study data cannot establish the safety of daily use over months or years. Follow the product directions and discuss ongoing use with a clinician if you have medications, health conditions, or concerns.
Can I take NAD+ with NMN?
There is no convincing human trial showing an added benefit or a well-characterized safety profile for that combination. Both belong to the NAD+ pathway; that biochemical relationship is not a reason to stack them.
Bottom line
Oral NAD+ has a small, formulation-specific human evidence base. Commonly repeated symptom lists are often borrowed from other molecules or routes, and long-term capsule safety is unknown. Choose a clearly labeled product, use it as directed, and treat any concerning symptom as a reason to pause and seek advice. Safety and benefit are separate questions, and neither can be settled by the ingredient's role inside cells.
Keep it useful
Join the conversation